1438 related articles for article (PubMed ID: 28505571)
1. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.
van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH
J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.
Tsai WY; Youn HH; Brites C; Tsai JJ; Tyson J; Pedroso C; Drexler JF; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
Clin Infect Dis; 2017 Nov; 65(11):1829-1836. PubMed ID: 29020159
[TBL] [Abstract][Full Text] [Related]
3. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016.
Steinhagen K; Probst C; Radzimski C; Schmidt-Chanasit J; Emmerich P; van Esbroeck M; Schinkel J; Grobusch MP; Goorhuis A; Warnecke JM; Lattwein E; Komorowski L; Deerberg A; Saschenbrecker S; Stöcker W; Schlumberger W
Euro Surveill; 2016 Dec; 21(50):. PubMed ID: 28006649
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.
Chao DY; Whitney MT; Davis BS; Medina FA; Munoz JL; Chang GJ
J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30541932
[TBL] [Abstract][Full Text] [Related]
5. Combination of Nonstructural Protein 1-Based Enzyme-Linked Immunosorbent Assays Can Detect and Distinguish Various Dengue Virus and Zika Virus Infections.
Tyson J; Tsai WY; Tsai JJ; Brites C; Mässgård L; Ha Youn H; Pedroso C; Drexler JF; Stramer SL; Balmaseda A; Harris E; Wang WK
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30429254
[TBL] [Abstract][Full Text] [Related]
6. Validation of serological and molecular methods for diagnosis of zika virus infections.
Jääskeläinen AJ; Korhonen EM; Huhtamo E; Lappalainen M; Vapalahti O; Kallio-Kokko H
J Virol Methods; 2019 Jan; 263():68-74. PubMed ID: 30342068
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research.
Low SL; Leo YS; Lai YL; Lam S; Tan HH; Wong JCC; Tan LK; Ng LC
PLoS One; 2021; 16(1):e0244601. PubMed ID: 33497414
[TBL] [Abstract][Full Text] [Related]
8. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Anti-Dengue and Anti-Zika IgG on a Plasmonic Gold Platform with Neutralization Testing.
Rojas A; Natrajan MS; Weber J; Cardozo F; Cantero C; Ananta JS; Kost J; Tang M; López S; Bernal C; Guillén Y; Mendoza L; Páez M; Pinsky BA; Waggoner JJ
Am J Trop Med Hyg; 2021 Mar; 104(5):1729-1733. PubMed ID: 33782214
[TBL] [Abstract][Full Text] [Related]
10. Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.
Rockstroh A; Moges B; Barzon L; Sinigaglia A; Palù G; Kumbukgolla W; Schmidt-Chanasit J; Sarno M; Brites C; Moreira-Soto A; Drexler JF; Ferreira OC; Ulbert S
Emerg Microbes Infect; 2017 Nov; 6(11):e99. PubMed ID: 29116222
[TBL] [Abstract][Full Text] [Related]
11. Delayed and highly specific antibody response to nonstructural protein 1 (NS1) revealed during natural human ZIKV infection by NS1-based capture ELISA.
Gao X; Wen Y; Wang J; Hong W; Li C; Zhao L; Yin C; Jin X; Zhang F; Yu L
BMC Infect Dis; 2018 Jun; 18(1):275. PubMed ID: 29898684
[TBL] [Abstract][Full Text] [Related]
12. Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections.
Rönnberg B; Gustafsson Å; Vapalahti O; Emmerich P; Lundkvist Å; Schmidt-Chanasit J; Blomberg J
Med Microbiol Immunol; 2017 Oct; 206(5):383-401. PubMed ID: 28852878
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
[TBL] [Abstract][Full Text] [Related]
14. Development of Zika Virus Serological Testing Strategies in New York State.
Lee WT; Wong SJ; Kulas KE; Dupuis AP; Payne AF; Kramer LD; Dean AB; St George K; White JL; Sommer JN; Ledizet M; Limberger RJ
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263203
[TBL] [Abstract][Full Text] [Related]
15. Zika Virus Antibody Titers Three Years after Confirmed Infection.
Langerak T; Kasbergen LMR; Chandler F; Brinkman T; Faerber Z; Phalai K; Ulbert S; Rockstroh A; Bruin E; Koopmans MPG; Rockx B; van Gorp ECM; Vreden S
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372551
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of anti-Zika virus IgM, IgAM and IgG ELISAs during co-circulation of Zika, dengue, and chikungunya viruses in Brazil and Venezuela.
Morales I; Rosenberger KD; Magalhaes T; Morais CNL; Braga C; Marques ETA; Calvet GA; Damasceno L; Brasil P; Bispo de Filippis AM; Tami A; Bethencourt S; Alvarez M; Martínez PA; Guzman MG; Souza Benevides B; Caprara A; Quyen NTH; Simmons CP; Wills B; de Lamballerie X; Drexler JF; Jaenisch T;
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009336. PubMed ID: 33872309
[TBL] [Abstract][Full Text] [Related]
17. Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population.
Zaidi MB; Cedillo-Barron L; González Y Almeida ME; Garcia-Cordero J; Campos FD; Namorado-Tonix K; Perez F
Acta Trop; 2020 Jan; 201():105201. PubMed ID: 31562846
[TBL] [Abstract][Full Text] [Related]
18. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
[TBL] [Abstract][Full Text] [Related]
19. Molecular and serological techniques to detect co-circulation of DENV, ZIKV and CHIKV in suspected dengue-like syndrome patients.
Cabral-Castro MJ; Cavalcanti MG; Peralta RHS; Peralta JM
J Clin Virol; 2016 Sep; 82():108-111. PubMed ID: 27479173
[TBL] [Abstract][Full Text] [Related]
20. Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission.
Medina FA; Vila F; Premkumar L; Lorenzi O; Paz-Bailey G; Alvarado LI; Rivera-Amill V; de Silva A; Waterman S; Muñoz-Jordán J
Am J Trop Med Hyg; 2021 Dec; 106(2):585-592. PubMed ID: 34929668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
